Report Content
Chapter 1 Methodology & Scope
1.1 Market segmentation
1.2 Market definition
1.3 Research design
1.4 Market size estimates and calculations
1.5 Key trends for market estimates
1.6 Forecast model
1.7 Primary research & validation
1.7.1 Primary sources
1.7.2 Data mining sources
1.7.2.1 Paid sources
1.7.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis, 2018 – 2032
2.2 Product trends
2.3 Application trends
2.4 End-use trends
2.5 Regional trends
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing demand for regenerative medicine
3.2.1.2 Rising incidence of chronic wounds
3.2.1.3 Advancements in biotechnology and tissue engineering
3.2.1.4 Increasing awareness and acceptance of amniotic membrane products
3.2.2 Industry pitfalls & challenges
3.2.2.1 Limited shelf life of amniotic membrane products
3.2.2.2 Stringent regulatory polices
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By application
3.3.3 By end-use
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Technology landscape
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Cryopreserved
5.3 Lyophilized
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Surgical wounds
6.3 Ophthalmology
6.4 Stem cell biology
6.5 Regenerative medicine
6.6 Prenatal diagnosis
6.7 Orthopedics
6.8 Dermatology
6.9 Plastic surgery
6.10 Dentistry
6.11 Gynecology
Chapter 7 Market Estimates and Forecast, By End Use, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers (ASCs)
7.4 Specialty clinics
7.5 Research and academic institutes
7.6 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Amnio Technology, LLC
9.2 Applied Biologics LLC
9.3 BioTissue Holdings Inc.
9.4 Celularity Inc.
9.5 Corza Health, Inc.
9.6 Integra LifeSciences Holdings Corporation
9.7 MiMedx Group, Inc.
9.8 Organogenesis Holdings Inc.
9.9 Skye Biologics, Inc.
9.10 Smith & Nephew plc
